Diabetes, Obesity and Metabolism, 1462-8902

Tidskrift

Fler filtreringsmöjligheter
  1. A low glycaemic diet improves oral glucose tolerance but has no effect on β-cell function in C57BL/6J mice.

    Ulrika Axling, Rosén, L., Nils Wierup, Östman, E., Björck, I. & Cecilia Holm, 2010, I : Diabetes, Obesity and Metabolism. 12, 11, s. 976-982

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  2. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

    Östgren, C. J., Juan Merlo, Lennart Råstam & Lindblad, U., 2004, I : Diabetes, Obesity and Metabolism. 6, 5, s. 367-374

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. beta-Cell research - A decade of rapid growth

    Bo Ahrén, Accili, D., Boitard, C., Efendic, S., Henquin, J-C., Seino, S., Steiner, D. F. & Cerasi, E., 2009, I : Diabetes, Obesity and Metabolism. 11, s. IV-IX

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)

    Lindblad, U., Lindberg, G., Månsson, N-O., Jonas Ranstam, Tyrberg, M., Jansson, S., Lindwall, K., Svärdh, M., Kindmalm, L. & Melander, A., 2011, I : Diabetes, Obesity and Metabolism. 13, 2, s. 185-188

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.

    Bo Ahrén, Foley, J. E. & Bosi, E., 2011, I : Diabetes, Obesity and Metabolism. 13, 3, s. 193-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project

    Östgren, C. J., Lindblad, U., Bøg-Hansen, E., Jonas Ranstam, Melander, A. & Lennart Råstam, 1999, I : Diabetes, Obesity and Metabolism. 1, 2, s. 105-112

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients

    Alsalim, W., Margaretha Persson & Bo Ahrén, 2018 jul, I : Diabetes, Obesity and Metabolism. 20, 7, s. 1652-1658

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

    Monami, M., Bo Ahrén, Dicembrini, I. & Mannucci, E., 2013, I : Diabetes, Obesity and Metabolism. 15, 2, s. 112-120

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.

    Ola Lindgren, Carr, R., Holst, J. J., Deacon, C. & Bo Ahrén, 2011, I : Diabetes, Obesity and Metabolism. 13, s. 863-865

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery

    Guldstrand, M., Bo Ahrén, Naslund, E., Holst, J. J. & Adamson, U., 2009, I : Diabetes, Obesity and Metabolism. 11, 11, s. 1027-1033

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Editorial: Long in the shade, glucagon re-occupies centre court

    Henquin, J. -C., Accili, D., Bo Ahrén, Boitard, C., Seino, S. & Cerasi, E., 2011, I : Diabetes, Obesity and Metabolism. 13, Suppl. 1, s. V-VIII

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  12. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

    Lund, S. S., Tarnow, L., Astrup, A. S., Hovind, P., Jacobsen, P. K., Alibegovic, A. C., Parving, I., Pietraszek, L., Frandsen, M., Rossing, P., Parving, H. -H. & Allan Vaag, 2009, I : Diabetes, Obesity and Metabolism. 11, 10, s. 966-977

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects

    Alsalim, W., Olga Göransson, Carr, R. D., Bizzotto, R., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2018 apr, I : Diabetes, Obesity and Metabolism. 20, 4, s. 1080-1085

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes

    Jönsson, A., Bengt Hallengren, Rydberg, T. & Melander, A., 2001, I : Diabetes, Obesity and Metabolism. 3, 6, s. 403-409

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

    Yabe, D., Eto, T., Shiramoto, M., Irie, S., Murotani, K., Seino, Y., Kuwata, H., Kurose, T., Seino, S., Bo Ahrén & Seino, Y., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 442-447

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up

    Alvarsson, M., Sundkvist, G., Lager, I., Kerstin Berntorp, Fernqvist-Forbes, E., Steen, L., Örn, T., Holberg, M. A., Kirksaether, N. & Grill, V., 2008, I : Diabetes, Obesity and Metabolism. 10, 5, s. 421-429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Jauffret, S. & Foley, J. E., 2008, I : Diabetes, Obesity and Metabolism. 10, 8, s. 675-682

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.

    Hermann, LS., Lindberg, G., Lindblad, U. & Melander, A., 2002, I : Diabetes, Obesity and Metabolism. 4, 5, s. 296-304

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  19. Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Wang, Y., Dunning, B. E. & Foley, J. E., 2008, I : Diabetes, Obesity and Metabolism. 10, 11, s. 1114-1124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

    Ferrannini, E., Fonseca, V., Zinman, B., Matthews, D., Bo Ahrén, Byiers, S., Shao, Q. & Dejager, S., 2009, I : Diabetes, Obesity and Metabolism. 11, 2, s. 157-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Functional SOCS1 polymorphisms are associated with variation in obesity in whites

    Gylvin, T., Ek, J., Nolsoe, R., Albrechtsen, A., Andersen, G., Bergholdt, R., Brorsson, C., Bang-Berthelsen, C. H., Hansen, T., Karlsen, A. E., Billestrup, N., Borch-Johnsen, K., Jorgensen, T., Pedersen, O., Mandrup-Poulsen, T., Nerup, J. & Pociot, F., 2009, I : Diabetes, Obesity and Metabolism. 11, 3, s. 196-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.

    Alam, M., Van der Schueren, B. J., Bo Ahrén, Wang, G. C., Swerdlow, N. J., Arias, S., Bose, M., Gorroochurn, P., Teixeira, J., McGinty, J. & Laferrère, B., 2011, I : Diabetes, Obesity and Metabolism. 13, 4, s. 378-381

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Genetic basis of beta-cell dysfunction in man.

    Leif Groop & Valeriya Lyssenko, 2009, I : Diabetes, Obesity and Metabolism. 11 Suppl 4, s. 149-158

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.

    Lena Ohlsson, Alsalim, W., Carr, R. D., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2013, I : Diabetes, Obesity and Metabolism. 15, 6, s. 531-537

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data

    Brorsson, C., Hansen, N. T., Lage, K., Bergholdt, R., Brunak, S. & Pociot, F., 2009, I : Diabetes, Obesity and Metabolism. 11, S1, s. 60-66

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

    Bøg-Hansen, E., Lindblad, U., Ranstam, J., Melander, A. & Lennart Råstam, 2001, I : Diabetes, Obesity and Metabolism. 3, 1, s. 25-31

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.

    Vikman, J. & Bo Ahrén, 2009, I : Diabetes, Obesity and Metabolism. 11 Suppl 4, s. 197-201

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Islet adaptation to insulin resistance: mechanisms and implications for intervention.

    Bo Ahrén & Pacini, G., 2005, I : Diabetes, Obesity and Metabolism. 7, 1, s. 2-8

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  29. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    Nauck, M., Frid, A., Hermansen, K., Thomsen, A. B., During, M., Shah, N., Tankova, T., Mitha, I. & Matthews, D. R., 2013, I : Diabetes, Obesity and Metabolism. 15, 3, s. 204-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.

    Bo Ahrén, Schweizer, A., Dejager, S., Villhauer, E. B., Dunning, B. E. & Foley, J. E., 2011, I : Diabetes, Obesity and Metabolism. 13, 9, s. 775-783

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  31. Metabolic disorders associated with uncontrolled hypertension.

    Bøg-Hansen, E., Lindblad, U., Bo Gullberg, Melander, A. & Lennart Råstam, 2003, I : Diabetes, Obesity and Metabolism. 5, 6, s. 379-387

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study

    The SUMMIT consortium, Natali, A., Nesti, L., Venturi, E., Shore, A. C., Khan, F., Gooding, K., Gates, P. E., Looker, H. C., Dove, F., Isabel Goncalves, Margaretha Persson & Jan Nilsson, 2019 feb, I : Diabetes, Obesity and Metabolism. 21, 2, s. 412-416

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. MicroRNAs in islet hormone secretion

    Jonathan L.S. Esguerra, Mototsugu Nagao, Jones K. Ofori, Anna Wendt & Lena Eliasson, 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, Suppl 2, s. 11-19

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  34. Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.

    Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A. & Bo Ahrén, 2016, I : Diabetes, Obesity and Metabolism. 18, 1, s. 24-33

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Prediction of fat-free body mass from bioelectrical impedance among 9-to 11-year-old Swedish children

    Nielsen, B. M., Magnus Dencker, Ward, L., Christian Lindén, Ola Thorsson, Magnus Karlsson & Heitmann, B. L., 2007, I : Diabetes, Obesity and Metabolism. 9, 4, s. 521-539

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.

    Bo Ahrén, Gautier, J-F., Berria, R., Stager, W., Aronson, R. & Bailey, C. J., 2014, I : Diabetes, Obesity and Metabolism. 16, 9, s. 861-868

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg Hypertension and Diabetes Project.

    Jungå, K., Juan Merlo, Bo Gullberg, Bog-Hansen, E., Lennart Råstam & Lindblad, U., 2006, I : Diabetes, Obesity and Metabolism. 8, 5, s. 492-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report

    Tyrberg, M., Melander, A., Monica Lövestam Adrian & Lindblad, U., 2008, I : Diabetes, Obesity and Metabolism. 10, 8, s. 646-651

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

    Bo Ahrén, Atkin, S. L., Charpentier, G., Warren, M. L., Wilding, J. P. H., Birch, S., Holst, A. G. & Leiter, L. A., 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, 9, s. 2210-2219 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. Shifting the paradigm of islet inflammation-good guy or bad guy?

    Bo Ahrén, Accili, D., Boitard, C., Cerasi, E., Thorens, B. & Seino, S., 2013, I : Diabetes, Obesity and Metabolism. 15, s. 4-9

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  41. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    Alba, M., Bo Ahrén, Inzucchi, S. E., Guan, Y., Mallick, M., Xu, L., O'Neill, E. A., Williams-Herman, D. E., Kaufman, K. D. & Goldstein, B. J., 2013, I : Diabetes, Obesity and Metabolism. 15, 12, s. 1101-1110

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study.

    Lidfeldt, J., Nyberg, P., Nerbrand, C., Samsioe, G., Scherstén, B. & Agardh, C-D., 2003, I : Diabetes, Obesity and Metabolism. 5, 2, s. 106-112

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes

    Preiss, D., Dawed, A., Welsh, P., Heggie, A., Jones, A. G., Dekker, J., Robert Koivula, Hansen, T. H., Stewart, C., Holman, R. R., Paul W. Franks, Walker, M., Pearson, E. R. & Sattar, N., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 356-363

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa